Interleukin-35 is upregulated in systemic sclerosis and its serum levels are associated with early disease-Reference-Cited by-同舟云学术

Interleukin-35 is upregulated in systemic sclerosis and its serum levels are associated with early disease

Published:2015-07-31 Issue: Volume: Page:kev260
ISSN:1462-0324
Container-title:Rheumatology
language:en
Short-container-title:Rheumatology

Author:

Tomcik Michal,Zerr Pawel,Palumbo-Zerr Katrin,Storkanova Hana,Hulejova Hana,Spiritovic Maja,Kodet Ondrej,Stork Jiri,Becvar Radim,Vencovsky Jiri,Pavelka Karel,Filkova Maria,Distler Jörg H. W.,Senolt Ladislav

Publisher

Oxford University Press (OUP)

Subject

Pharmacology (medical),Rheumatology

Link

http://academic.oup.com/rheumatology/article-pdf/54/12/2273/17388492/kev260.pdf

Reference46 articles.

1. Scleroderma

2. Systemic sclerosis: a prototypic multisystem fibrotic disorder

3. Review: Evidence That Systemic Sclerosis Is a Vascular Disease

4. Interleukin-35: odd one out or part of the family?

5. The composition and signaling of the IL-35 receptor are unconventional

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunomodulatory effects of iTr35 cell subpopulation and its research progress;Clinical and Experimental Medicine;2024-02-22

2. Impaired Regulation by IL-35 in Systemic Sclerosis;International Journal of Molecular Sciences;2023-06-24

3. Current Trends in Vascular Biomarkers for Systemic Sclerosis: A Narrative Review;International Journal of Molecular Sciences;2023-02-17

4. The role of iTr35 cells in the inflammatory response and fibrosis progression of systemic sclerosis;Rheumatology;2023-02-03

5. The role of salusins and interleukin 12 family in the rosacea pathogenesis;Turkish Journal of Dermatology;2023